Remdesivir has been one of the most closely watched potential therapies for COVID-19, and a couple of early cohort and observational studies have been encouraging. But apparently the first results from a randomized controlled trial in China indicate that it did not make a statistically significant difference. At least, it looks that way: results were accidentally posted on the WHO website and then removed, with a promise of an official publication to come later. It's all a bit murky, and there's a number of other trials ongoing, but this is not the sort of result you hope to see, even accidentally.
recent posts
- Protecting Data: Regulation, Contract, or Privacy
- Foucault, Hyppolite and Marx (part 1): Have you had your Stalin today?
- Algorithmic Right to an Explanation (or not) and the non-ideal US Legal System
- New paper: “Erasing Agonism: How Algorithmic Governance goes further than Leviathan”
- Reading List: Paolo Caffoni, “The Cost of Language”
New APPS 
Leave a comment